Health tech company Detect announced Friday it had received emergency use authorization from the Food and Drug Administration for its at-home molecular COVID-19 test.
The Detect test uses an app to help users perform and interpret their results. The company said it's also working on an electronic travel pass system with a telehealth service so its offering can be used for travel and events.
“...
